Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls

Recent advances in medical and surgical therapy were achieved during the last two decades in the management of Crohn's disease (CD). Anti-tumor necrosis factor (anti-TNF) agents are widely used worldwide. However, a significant proportion of patients still need surgical resections. The impact o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotze, Paulo Gustavo, Ghosh, Subrata, Bemelman, Willem A., Panaccione, Remo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430006/
https://www.ncbi.nlm.nih.gov/pubmed/28522944
http://dx.doi.org/10.5217/ir.2017.15.2.160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430006/
https://www.ncbi.nlm.nih.gov/pubmed/28522944
http://dx.doi.org/10.5217/ir.2017.15.2.160

Ejemplares similares